Centenial Surgical Suture Ltd (CSURGSU)

Loading page…

Centenial Surgical Suture Ltd (CSURGSU) · mywealthgrid

About

Centenial Surgical Suture Ltd operates in Medical Equipment & Supplies within the Healthcare sector.

Face value: ₹10

Market cap

₹37 Cr

P/E

39.3×

P/B

1.3×

Dividend yield

ROE

-7.4%

ROCE

2.5%

Debt / equity

0.38

OPM

9.5%

EPS (TTM)

₹2.6

Book value

₹79.3

52-week high

—

52-week low

—

1,583 historical price candles were omitted because the exchange source has not been verified.

₹102.0-0.8%1Y

Quick read

rule-based

Pros

No positive flags triggered.

Cons

−Low return on equity of -2.8% (3-yr avg)
−Modest revenue growth of 7.8% a year over the last 5 years
−Weak interest coverage of 0.4×

Research score

Structured signal from quality, growth, valuation and momentum.

27/100

Business quality: 19
Growth: 1
Valuation: 60

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore · years without a filed annual are summed from quarters

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	51	53	53	56	56	37	44	53	51	54	54
COGS	-9	-26	-24	-25	-24	10	20	20	17	17	19
Gross profit	—	—	—	—	—	27	25	33	34	36	35
	56	74	72	76	74	22	20	28	29	30	30
	4	5	4	5	6	5	4	4	5	6	5
OPM %	8%	9%	8.3%	9.4%	10.4%	13.5%	10%	8.2%	9.8%	11.7%	9.5%
Depreciation	—	1	1	1	2	2	2	1	1	4	4
Interest	2	2	1	2	2	2	2	2	2	4	3
	—	0	—	—	0	0	0	0	0	0	0
Profit before tax	2	3	2	3	2	2	1	1	1	-2	-2
Tax	1	1	1	1	1	1	0	1	0	-0	0
Tax %	34%	32.6%	36.1%	29.2%	33.3%	37.3%	42.1%	39.7%	11%	-9.3%	5.8%
	2	2	2	2	1	1	1	1	1	-1	-2
PAT margin %	3%	3.3%	2.9%	3.6%	2.6%	2.6%	1.4%	1.7%	2.2%	-2.7%	-4.1%
EPS (₹)	4.2	4.7	4.2	4.4	4	2.6	—	2.4	3.1	—	-6
EPS adjusted (₹)	2.9	3.2	2.8	3.7	2.7	1.8	1.2	1.6	2.1	-2.7	-4.1
Annual report	Annual report for Mar 2016	Annual report for Mar 2017	Annual report for Mar 2018	Annual report for Mar 2019	Annual report for Mar 2020	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	5	5	5	5	5	5	5	5	5	5	5
Reserves	17	17	21	23	23	24	25	26	27	25	23
Minority interest	—	0	—	0	0	—	0	—	0	—	—
	13	—	—	—	—	0	0	0	0	0	11
	17	30	29	29	41	40	31	35	47	54	41
Total equity & liabilities	53	53	55	57	69	70	61	66	79	85	80
	4	4	4	4	10	9	8	6	13	20	18
CWIP	0	0	0	0	0	—	0	—	—	—	0
Investments	0	—	—	—	—	0	0	0	0	0	0
	49	49	51	52	59	61	54	60	66	65	62
Total assets	53	53	55	57	69	70	61	66	79	85	80

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	71.9%	55.8%	61.9%	66.7%	67.8%	65.2%
EBITDA margin %	9.4%	10.4%	13.5%	10%	8.2%	9.8%	11.7%	9.5%
EBIT margin %	8.1%	7.6%	9.3%	6.6%	5.7%	7.1%	3.8%	2%
PAT margin %	3.6%	2.6%	2.6%	1.4%	1.7%	2.2%	-2.7%	-4.1%
Working capital
Receivable days	135	153	221	160	143	134	125	124
Inventory days	214	236	1,276	599	677	910	922	791
Payable days	59	92	373	159	222	208	152	146
NWC days	290	298	1,125	601	598	836	895	770
Leverage
Current ratio	2	1.87	1.92	2.2	2.04	1.99	1.98	1.9
Debt to EBITDA	—	—	0	0	0	0	0	2.1
Debt to equity	—	—	0	0	0	0	0	0.38
Interest coverage	2.6	2	1.8	1.6	1.9	1.5	0.6	0.4
Asset turnover	0.99	0.8	0.53	0.72	0.79	0.65	0.63	0.67
Return ratios
Return on assets %	3.6%	2.1%	1.4%	1%	1.3%	1.4%	-1.7%	-2.8%
Return on capital employed %	15.3%	12.6%	9.2%	7.8%	8.4%	9%	4.3%	2.5%
Return on equity %	7.2%	5%	3.2%	2.1%	2.9%	3.5%	-4.7%	-7.7%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%	46.89%
FII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
DII	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Government	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%	53.11%
No. of shareholders	—	—	—	—	—	—	—	—	1,193	1,200	1,182	1,165

Promoter holding up 0 percentage points since Sep 2023.

4 deals · 24 May 2023 – 27 Jun 2023

Date	Client	Type	Venue	Side	Quantity	Price	Value
27 Jun 2023	VIJAY KALIDAS MAJREKAR	Bulk	BSE	Buy	51,326	₹64.15	₹0.33 Cr
27 Jun 2023	VIPUL NAVINCHANDRA SHAH	Bulk	BSE	Sell	28,849	₹64.15	₹0.19 Cr
24 May 2023	VIPUL NAVINCHANDRA SHAH	Bulk	BSE	Buy	28,849	₹64.75	₹0.19 Cr
24 May 2023	SHREE BHUVANAKARAM TRADINVEST PVT LTD	Bulk	BSE	Sell	28,849	₹64.75	₹0.19 Cr

1–4 of 4

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. VIJAY KALIDAS MAJREKARExecutive Director-Chairperson-CEO-MD
Ms. ANURADHA RAGHUNANDAN KASHIKARExecutive Director
Mr. DEVRAJ THANIYA POOJARYExecutive Director
Mr. NEEL MUKESH VORANon-Executive - Independent Director
Mr. AKASH SUNIL MODINon-Executive - Independent Director
Mr. ANUJ VIPULBHAI SHAHNon-Executive - Independent Director
Ms. RIDHIMA BHUSHAN LIMAYENon-Executive - Independent Director
Mrs. Mahima BathwalCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Centenial Surgical Suture Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

1

Board meeting to consider results14 Aug 2026

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

19 announcementsExport CSV

26 Aug 2026, 4:37 pmCompany Update

Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise

General PDF

17 Aug 2026, 3:51 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

14 Aug 2026, 7:28 pmAGM/EGM

Intimation Of 31St Annual General Meeting (AGM) Of The Company, Cut-Off Date For Voting And E-Voting As Per Regulation 44 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]), Regulations, 2015.

AGM PDF

14 Aug 2026, 7:15 pmCorp. Action

Notice Of Book Closure As Per Regulation 42 Of The SEBI (Listing Obligations And Disclosures Requirements [LODR]), Regulations, 2015 For The Purpose Of 31St Annual General Meeting (E-AGM) To Be Held On September 28, 2026

Book Closure PDF

14 Aug 2026, 6:58 pmCompany Update

Re-Appointment Of Whole Time Director Of The Company - Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('The SEBI Listing Regulation').

General PDF

14 Aug 2026, 6:55 pmCompany Update

Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

Resignation of Chief Financial Officer (CFO) PDF

14 Aug 2026, 6:48 pmCompany Update

Intimation Of Appointment Of Internal Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

General PDF

14 Aug 2026, 6:28 pmResult

Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2026

Financial Results PDF

Date	Category	Subject	Filing
26 Aug 2026, 4:37 pm	Company Update General	Price Of The Scrip Of Our Company Has Seen An Abnormal Price Rise	PDF
17 Aug 2026, 3:51 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF

Loading announcements…

Ratio	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	—	—	71.9%	55.8%	61.9%	66.7%	67.8%	65.2%
EBITDA margin %	9.4%	10.4%	13.5%	10%	8.2%	9.8%	11.7%	9.5%
EBIT margin %	8.1%	7.6%	9.3%	6.6%	5.7%	7.1%	3.8%	2%
PAT margin %	3.6%	2.6%	2.6%	1.4%	1.7%	2.2%	-2.7%	-4.1%
Working capital
Receivable days	135	153	221	160	143	134	125	124
Inventory days	214	236	1,276	599	677	910	922	791
Payable days	59	92	373	159	222	208	152	146
NWC days	290	298	1,125	601	598	836	895	770
Leverage
Current ratio	2	1.87	1.92	2.2	2.04	1.99	1.98	1.9
Debt to EBITDA	—	—	0	0	0	0	0	2.1
Debt to equity	—	—	0	0	0	0	0	0.38
Interest coverage	2.6	2	1.8	1.6	1.9	1.5	0.6	0.4
Asset turnover	0.99	0.8	0.53	0.72	0.79	0.65	0.63	0.67
Return ratios
Return on assets %	3.6%	2.1%	1.4%	1%	1.3%	1.4%	-1.7%	-2.8%
Return on capital employed %	15.3%	12.6%	9.2%	7.8%	8.4%	9%	4.3%	2.5%
Return on equity %	7.2%	5%	3.2%	2.1%	2.9%	3.5%	-4.7%	-7.7%

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Molbio Diagnostics LimitedMOLBIOMOLBIO	₹17,431 Cr	₹17,844 Cr	₹1,020 Cr	₹262 Cr	25.7%	₹145 Cr	13.6%	23.7%	16.2%	—
Poly Medicure LimitedPOLYMEDPOLYMED	₹16,610 Cr	₹16,952 Cr	₹1,997 Cr	₹461 Cr	23.6%	₹315 Cr	17.1%	14.5%	11%	294
Fischer Medical Ventures LimitedFISCHERFISCHER	₹2,190 Cr	₹2,262 Cr	₹367 Cr	₹50 Cr	14%	₹30 Cr	10.1%	13.6%	8.6%	111
Tarsons Products LimitedTARSONSTARSONS	₹1,752 Cr	₹2,135 Cr	₹441 Cr	₹119 Cr	27.9%	₹11 Cr	3.4%	5%	2.3%	361
Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL	₹1,066 Cr	₹1,066 Cr	₹287 Cr	₹46 Cr	15.6%	₹31 Cr	10.4%	14.7%	12.8%	109
Hemant Surgical Industries LtdHSILHSIL	₹885 Cr	—	₹232 Cr	₹23 Cr	10%	₹18 Cr	7.9%	—	—	—
Fabtech Technologies LimitedFABTECHFABTECH	₹632 Cr	₹675 Cr	₹418 Cr	₹45 Cr	8.5%	₹49 Cr	9.3%	15.5%	12.9%	55
Prevest Denpro LtdPREVESTPREVEST	₹452 Cr	—	₹72 Cr	₹25 Cr	34.4%	₹20 Cr	28.5%	—	—	—
Nureca LimitedNURECANURECA	₹332 Cr	₹333 Cr	₹153 Cr	₹4 Cr	0.1%	₹4 Cr	1.4%	3.3%	1.1%	186
Earkart LtdEARKARTEARKART	₹179 Cr	₹179 Cr	₹54 Cr	₹8 Cr	15.5%	₹5 Cr	9.1%	12.1%	7.7%	243
Choksi Asia LtdCHOKSICHOKSI	₹117 Cr	₹119 Cr	₹11 Cr	₹-2 Cr	13.8%	₹2 Cr	10.8%	18.9%	13.5%	142
Shree Pacetronix LtdSHREEPACSHREEPAC	₹68 Cr	₹71 Cr	₹8 Cr	₹1 Cr	23.5%	₹0 Cr	14%	27.4%	18.9%	385

₹ Cr	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-2	0	2	2	2	-0	3	-0	4	13	4
	-0	-2	-1	-1	-1	-1	-0	-0	-8	-12	-2
	1	2	-1	-1	-0	1	-3	1	5	-2	-2
Net cash flow	-1	-0	0	-1	0	-0	-0	0	0	-0	-0
Free cash flow	-2	-1	1	1	1	-1	3	-1	-4	2	2
CFO / Operating profit %	-36.9%	0%	40%	29.5%	35.9%	-1%	64.3%	-8.6%	74.9%	212.6%	78.4%

Centenial Surgical Suture Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Ratios

Ratio timeline

Shareholding

Quarterly record

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

Board meetings1

Announcements

Ratio timeline

Quarterly record

Bulk & block deals

Board and management

Not in the F&O segment

No fund holdings on record

Board meetings1

Announcements

Annual reports

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Return on equity

1

1